The p-tau217 blood test predicts a 38% risk of cognitive impairment within 5 years.
Summary: A new study establishes the long-term prognostic power of the blood-based biomarker p-tau217. The analysis reveals that asymptomatic individuals presenting with very high baseline p-tau217 c… [+15833 chars]